Comment on an article: "Osteoporosis in the age of COVID-19 patients".
作者信息
Ibrahimagić O Ć, Vujadinović A, Ercegović Z, Kunić S, Smajlović Dž, Dostović Z
机构信息
Department of Neurology, University Clinical Centre Tuzla, 75000, Tuzla, Bosnia and Herzegovina.
Department of Orthopaedics and Traumatology, University Clinical Centre Tuzla, 75000, Tuzla, Bosnia and Herzegovina.
出版信息
Osteoporos Int. 2021 Apr;32(4):783-784. doi: 10.1007/s00198-020-05607-6. Epub 2021 Jan 21.
Abstract
摘要
相似文献
1
Comment on an article: "Osteoporosis in the age of COVID-19 patients".对一篇文章的评论：“新冠疫情患者中的骨质疏松症”
Osteoporos Int. 2021 Apr;32(4):783-784. doi: 10.1007/s00198-020-05607-6. Epub 2021 Jan 21.
2
Reply to Comment on "Osteoporosis in the Age of COVID-19".对《新冠疫情时代的骨质疏松症》评论的回复
Osteoporos Int. 2021 Apr;32(4):795. doi: 10.1007/s00198-021-05901-x. Epub 2021 Mar 4.
3
What can we learn about corticosteroid therapy as a treatment for COVID-19?关于皮质类固醇疗法作为治疗新冠肺炎的方法，我们能了解到什么？
Osteoporos Int. 2020 Aug;31(8):1595. doi: 10.1007/s00198-020-05487-w. Epub 2020 Jun 9.
4
Long-term Outcome of Short-course High-dose Glucocorticoids for Severe Acute Respiratory Syndrome (SARS): A 17-Year Follow-up in SARS Survivors.短疗程大剂量糖皮质激素治疗严重急性呼吸综合征（SARS）的长期结局：对SARS幸存者的17年随访
Clin Infect Dis. 2021 May 18;72(10):1830-1833. doi: 10.1093/cid/ciaa992.
5
COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey.2019冠状病毒病及其对骨质疏松症管理的影响：来自美国国家骨质疏松症基金会调查的患者视角
Osteoporos Int. 2021 Apr;32(4):619-622. doi: 10.1007/s00198-021-05836-3. Epub 2021 Feb 8.
6
Glucocorticoids save lives in COVID-19 patients.糖皮质激素可拯救 COVID-19 患者的生命。
Int J Biol Sci. 2020 Jul 7;16(13):2477-2478. doi: 10.7150/ijbs.49125. eCollection 2020.
7
Author response to: Comment on: Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.作者对以下内容的回应：对一名患有重症呼吸道型新冠肺炎的危重症患者的腹腔积液样本（严重急性呼吸综合征冠状病毒2检测呈阴性）的评论。
Br J Surg. 2020 Nov;107(12):e624. doi: 10.1002/bjs.11898. Epub 2020 Sep 19.
8
Adrenal insufficiency in the COVID-19 era.新冠疫情时代的肾上腺功能不全
Am J Physiol Endocrinol Metab. 2021 Apr 1;320(4):E784-E785. doi: 10.1152/ajpendo.00061.2021.
9
"Comment on the article titled "Nosocomial SARS-CoV-2 transmission in postoperative infection and mortality: analysis of 14 798 procedures" by Elliott JA et al.评 Elliott JA 等人的文章“术后感染和死亡率中的医院内 SARS-CoV-2 传播：14798 例手术分析”
Br J Surg. 2021 Jan 27;108(1):e53. doi: 10.1093/bjs/znaa102.
10
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.移植受者感染 SARS-CoV-2 的药物治疗：治疗药物监测和药物相互作用的考虑因素。
Ther Drug Monit. 2020 Jun;42(3):360-368. doi: 10.1097/FTD.0000000000000761.
引用本文的文献
1
Biased, wrong and counterfeited evidences published during the COVID-19 pandemic, a systematic review of retracted COVID-19 papers.新冠疫情期间发表的有偏见、错误和伪造的证据：对撤回的新冠论文的系统评价
Qual Quant. 2022 Nov 29:1-33. doi: 10.1007/s11135-022-01587-3.
本文引用的文献
1
Osteoporosis in the age of COVID-19.COVID-19 时代的骨质疏松症。
Osteoporos Int. 2020 Jul;31(7):1189-1191. doi: 10.1007/s00198-020-05413-0. Epub 2020 Apr 28.
2
Magnitude of fragility fracture risk in the very old--are we meeting their needs? The Newcastle 85+ Study.高龄老人脆性骨折风险的程度——我们是否满足了他们的需求？纽卡斯尔85岁及以上老人研究。
Osteoporos Int. 2015 Jan;26(1):123-30. doi: 10.1007/s00198-014-2837-8. Epub 2014 Sep 16.
3
Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.左旋多巴治疗的帕金森病患者高同型半胱氨酸血症复发。
Eur J Neurol. 2010 May;17(5):661-5. doi: 10.1111/j.1468-1331.2009.02894.x. Epub 2009 Dec 27.
4
Australian work in first aid of poisonous snakebite.澳大利亚在毒蛇咬伤急救方面的工作。
Ann Emerg Med. 1982 Apr;11(4):228. doi: 10.1016/s0196-0644(82)80505-2.
Zotero 插件